The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 486.00
Bid: 485.50
Ask: 489.00
Change: 0.00 (0.00%)
Spread: 3.50 (0.721%)
Open: 480.00
High: 489.50
Low: 480.00
Prev. Close: 486.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

5 Apr 2018 07:00

RNS Number : 8730J
Treatt PLC
05 April 2018
 

 

 

5 April 2018

 

TREATT PLC

("Treatt" or "the Group")

 

Trading Update for the half year ended 31 March 2018

 

Treatt, the manufacturer and supplier of innovative ingredient solutions for the flavour, fragrance, beverage and consumer product industries today publishes a trading update for the half year ended 31 March 2018.

 

The Board is pleased to confirm that following a strong result for the financial year ended 30 September 2017 in which profit before tax increased by 46%, the business has continued to perform well in the current financial year with revenue for the six months ended 31 March 2018 up by approximately 11% compared to the same period in the prior year.

 

The core business categories of citrus, tea and sugar reduction have continued to drive top-line growth with the combined effect of new business wins in the prior year, together with further wins in the current year, beginning to take hold.

 

Whilst the Group has in place a hedging strategy to try to ensure that the impact of exchange rate movements is broadly neutral to the income statement over the course of a financial year, as has been experienced previously, there can be material effects over shorter periods of time. In the first half of the current financial year ("H1 2018") there was a weakening in the USD/GBP exchange rate and as a result the Board anticipates that there will be a small negative net FX impact on the H1 2018 results of approximately £0.2m.

 

The recently enacted Tax Cuts and Jobs Act in the United States is expected to result in a material reduction in the Group's overall tax charge. Firstly, the reduction in the headline federal income tax rate from 35% to 21% will reduce the current tax rate on the Group's US profits to 24.5% and further reduce the tax rate to 21% for the financial year ending 30 September 2019. In addition, the Board expects a one-off deferred tax credit of approximately $0.5m (£0.4m). The US tax charge is also likely to be reduced further under the Foreign Derived Intangible Income Tax regime on exports out of the US business. The Group will continue to work through the full impact of these changes as further guidance becomes available, but it is expected that the Group's overall tax charge will be materially lower than would have been the case under previous US tax law.

 

Outlook

The momentum which is being delivered by the Board's Strategic Plan, with its focus on core product categories and key geographical markets, is expected to continue in the second half of the current financial year and beyond. The Board therefore continues to believe that profit before tax and exceptional items will be in line with its expectations for the financial year ending 30 September 2018.

 

The Board expects to announce Treatt's half year results for the six months ended 31 March 2018 on 8 May 2018.

 

 

 

Enquiries:

 

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Broker

Investec Investment Banking

Patrick Robb +44 (0)20 7597 5970

David Anderson

Alex Wright

 

Public relations

DRD Partnership

Lawrence Dore +44 (0)20 3865 5971

 

About the Group

Treatt is a global, independent supplier of innovative ingredient solutions for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America, Africa and Asia and has manufacturing facilities in the UK, USA and Kenya. Its international foot print enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

 

For further information about the Group, visit www.treatt.com.

 

 

 

 

 

 

 

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLDSAISIIT
Date   Source Headline
8th Feb 20225:06 pmRNSStandard Form for notification of major holdings
28th Jan 20223:29 pmRNSResult of AGM
28th Jan 20227:00 amRNSAGM Trading Update
25th Jan 20223:50 pmRNSStandard Form for notification of major holdings
20th Jan 202212:18 pmRNSConfirmation of AGM arrangements
17th Jan 20229:36 amRNSBoard Appointments
14th Jan 20229:30 amRNSVoting Rights and Capital
20th Dec 20216:16 pmRNSNotification of Transactions of Director
16th Dec 20215:50 pmRNSNotification of Transactions of Director & PCA
14th Dec 20219:07 amRNSAnnual Report
8th Dec 20214:49 pmRNSStandard form for notification of major holdings
8th Dec 20214:46 pmRNSStandard form for notification of major holdings
6th Dec 202112:32 pmRNSNotification of Transactions of Director
6th Dec 20218:58 amRNSStandard form for notification of major holdings
1st Dec 20215:25 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20215:20 pmRNSBLOCK LISTING SIX MONTHLY RETURN
30th Nov 20217:00 amRNSFull Year Results
26th Nov 20218:25 amRNSDirector Declaration
9th Nov 20215:11 pmRNSStandard form for notification of major holdings
18th Oct 20215:58 pmRNSStandard form for notification of major holdings
18th Oct 202110:29 amRNSStandard form for notification of major holdings
15th Oct 20214:25 pmRNSStandard form for notification of major holdings
11th Oct 20217:00 amRNSTrading Update
7th Oct 20214:07 pmRNSNotification of Transactions of a PCA
4th Oct 20214:54 pmRNSTotal Voting Rights
4th Oct 202110:30 amRNSDirector/PDMR Shareholding
21st Sep 20212:25 pmRNSChange of Registered Office
21st Sep 202111:50 amRNSDirector/PDMR Shareholding
21st Sep 20219:50 amRNSHolding(s) in Company
15th Sep 20213:02 pmRNSHolding(s) in Company
9th Sep 20219:59 amRNSStandard form for notification of major holdings
8th Sep 20215:24 pmRNSNotification of Transactions of Directors and PCA
3rd Sep 20215:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20215:38 pmRNSNotification of Transaction of Director & PCA
25th Aug 20211:20 pmRNSHolding(s) in Company
23rd Aug 20215:05 pmRNSHolding(s) in Company
18th Aug 202112:30 pmRNSDirector/PDMR Shareholding
17th Aug 20217:00 amRNSBoard Change
13th Aug 20216:25 pmRNSDirector/PDMR Shareholding
9th Aug 20211:50 pmRNSNotification of Transactions of Director
20th Jul 20215:50 pmRNSHolding(s) in Company
14th Jul 20214:17 pmRNSNotification of Transactions of a PCA
14th Jul 20214:15 pmRNSDirector/PDMR Shareholding
30th Jun 20217:00 amRNSBoard Update
24th Jun 20215:16 pmRNSHolding(s) in Company
10th Jun 202111:25 amRNSHolding(s) in Company
10th Jun 202110:00 amRNSBoard Change
1st Jun 20215:14 pmRNSBlock Listing Six Monthly Return
1st Jun 20215:13 pmRNSBlock Listing Six Monthly Return
26th May 202111:57 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.